5aef: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Electron cryo-microscopy of an Abeta(1-42)amyloid fibril== | ==Electron cryo-microscopy of an Abeta(1-42)amyloid fibril== | ||
<StructureSection load='5aef' size='340' side='right' caption='[[5aef]], [[Resolution|resolution]] 5.00Å' scene=''> | <StructureSection load='5aef' size='340' side='right'caption='[[5aef]], [[Resolution|resolution]] 5.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5aef]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5AEF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5AEF FirstGlance]. <br> | <table><tr><td colspan='2'>[[5aef]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5AEF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5AEF FirstGlance]. <br> | ||
Line 17: | Line 17: | ||
==See Also== | ==See Also== | ||
*[[Amyloid precursor protein|Amyloid precursor protein]] | *[[Amyloid precursor protein 3D structures|Amyloid precursor protein 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | |||
[[Category: Fandrich, M]] | [[Category: Fandrich, M]] | ||
[[Category: Grigorieff, N]] | [[Category: Grigorieff, N]] |
Revision as of 13:48, 2 October 2019
Electron cryo-microscopy of an Abeta(1-42)amyloid fibrilElectron cryo-microscopy of an Abeta(1-42)amyloid fibril
Structural highlights
Publication Abstract from PubMedAlzheimer's disease (AD) is a fatal neurodegenerative disorder in humans and the main cause of dementia in aging societies. The disease is characterized by the aberrant formation of beta-amyloid (Abeta) peptide oligomers and fibrils. These structures may damage the brain and give rise to cerebral amyloid angiopathy, neuronal dysfunction, and cellular toxicity. Although the connection between AD and Abeta fibrillation is extensively documented, much is still unknown about the formation of these Abeta aggregates and their structures at the molecular level. Here, we combined electron cryomicroscopy, 3D reconstruction, and integrative structural modeling methods to determine the molecular architecture of a fibril formed by Abeta(1-42), a particularly pathogenic variant of Abeta peptide. Our model reveals that the individual layers of the Abeta fibril are formed by peptide dimers with face-to-face packing. The two peptides forming the dimer possess identical tilde-shaped conformations and interact with each other by packing of their hydrophobic C-terminal beta-strands. The peptide C termini are located close to the main fibril axis, where they produce a hydrophobic core and are surrounded by the structurally more flexible and charged segments of the peptide N termini. The observed molecular architecture is compatible with the general chemical properties of Abeta peptide and provides a structural basis for various biological observations that illuminate the molecular underpinnings of AD. Moreover, the structure provides direct evidence for a steric zipper within a fibril formed by full-length Abeta peptide. Peptide dimer structure in an Abeta(1-42) fibril visualized with cryo-EM.,Schmidt M, Rohou A, Lasker K, Yadav JK, Schiene-Fischer C, Fandrich M, Grigorieff N Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11858-63. doi:, 10.1073/pnas.1503455112. Epub 2015 Sep 8. PMID:26351699[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
|